Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children
- PMID: 11372032
- DOI: 10.1086/320740
Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children
Abstract
Amebiasis is the third leading parasitic cause of death worldwide, and it is not known whether immunity is acquired from a previous infection. An investigation was done to determine whether protection from intestinal infection correlated with mucosal or systemic antibody responses to the Entamoeba histolytica GalNAc adherence lectin. E. histolytica colonization was present in 0% (0/64) of children with and 13.4% (33/246) of children without stool IgA anti-GalNAc lectin antibodies (P= .001). Children with stool IgA lectin-specific antibodies at the beginning of the study had 64% fewer new E. histolytica infections by 5 months (3/42 IgA(+) vs. 47/227 IgA(-); P= .03). A stool antilectin IgA response was detected near the time of resolution of infection in 67% (12/18) of closely monitored new infections. It was concluded that a mucosal IgA antilectin antibody response is associated with immune protection against E. histolytica colonization. The demonstration of naturally acquired immunity offers hope for a vaccine to prevent amebiasis.
Similar articles
-
Role of mucosal secretory immunity in the development of an amebiasis vaccine.Am J Trop Med Hyg. 1994;50(5 Suppl):36-41. Am J Trop Med Hyg. 1994. PMID: 8203722 Review.
-
Innate and acquired resistance to amebiasis in bangladeshi children.J Infect Dis. 2002 Aug 15;186(4):547-52. doi: 10.1086/341566. Epub 2002 Jul 19. J Infect Dis. 2002. PMID: 12195383
-
Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response.Infect Immun. 2006 Jul;74(7):3897-903. doi: 10.1128/IAI.02018-05. Infect Immun. 2006. PMID: 16790762 Free PMC article.
-
Intestinal antilectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess.Infect Immun. 2003 Dec;71(12):6899-905. doi: 10.1128/IAI.71.12.6899-6905.2003. Infect Immun. 2003. PMID: 14638778 Free PMC article.
-
Protective immunity to amebiasis: new insights and new challenges.J Infect Dis. 2001 Aug 15;184(4):504-6. doi: 10.1086/322046. Epub 2001 Jul 6. J Infect Dis. 2001. PMID: 11471109 Review.
Cited by
-
miRNA, New Perspective to World of Intestinal Protozoa and Toxoplasma.Acta Parasitol. 2024 Sep;69(3):1690-1703. doi: 10.1007/s11686-024-00888-x. Epub 2024 Aug 19. Acta Parasitol. 2024. PMID: 39158784 Review.
-
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.Hum Vaccin Immunother. 2024 Dec 31;20(1):2374147. doi: 10.1080/21645515.2024.2374147. Epub 2024 Aug 1. Hum Vaccin Immunother. 2024. PMID: 39090779 Free PMC article.
-
Amebiasis as a sexually transmitted infection: A re-emerging health problem in developed countries.Glob Health Med. 2023 Dec 31;5(6):319-327. doi: 10.35772/ghm.2023.01064. Glob Health Med. 2023. PMID: 38162428 Free PMC article. Review.
-
Bat-associated microbes: Opportunities and perils, an overview.Heliyon. 2023 Nov 18;9(12):e22351. doi: 10.1016/j.heliyon.2023.e22351. eCollection 2023 Dec. Heliyon. 2023. PMID: 38125540 Free PMC article. Review.
-
Sex Difference in Amebiasis.Curr Top Microbiol Immunol. 2023;441:209-224. doi: 10.1007/978-3-031-35139-6_8. Curr Top Microbiol Immunol. 2023. PMID: 37695430
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous